| Literature DB >> 20831911 |
Jiang Ning Liu1, Wei Wang, Jian Ying Duo, Yi Hao, Chun Mei Ma, Wan Bo Li, Shu Zhu Lin, Xue Zhong Gao, Xiao Lin Liu, Yan Feng Xu, Wen-Bo Xu, Chuan Qin, Lian Feng Zhang.
Abstract
Human enterovirus 71 (EV71) is a cause of hand, foot and mouth disease (HMFD) in children under 6 years old, and could cause serious neurological complications in some patients. Numerous large outbreaks of EV71 caused HMFD have occurred recently in Asia, especially in China. The cross-reactivity of EV71 with human brain tissue was observed and the cross-reactivity inducing regions were identified in previously study, which suggested that there were two regions in structural proteins of virus should be avoided in the vaccine. Six peptides without cross-reactivity were selected and combined into three vaccine candidates and applied in further evaluation in neonatal mice. The Vac6 comprising the peptides of P(70-159), P(140-249), P(324-443) and P(746-876) of the structural proteins could provide effective protection on pups against virus infection, as shown in viral copies detection and histopathology examination. Immunohistochemical staining results indicated that Vac6 had no cross-reactivity with human brain tissues. Our results suggested that Vac6 could have potential clinical value against EV71 epidemics caused mainly by C4 strains in the mainland of China. CrownEntities:
Mesh:
Substances:
Year: 2010 PMID: 20831911 DOI: 10.1016/j.vaccine.2010.08.080
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641